Bank of America’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3K | Sell |
6,913
-22,996
| -77% | -$184K | ﹤0.01% | 5783 |
|
|
2025
Q1 | $292K | Sell |
29,909
-7,601
| -20% | -$74.2K | ﹤0.01% | 5021 |
|
|
2024
Q4 | $474K | Buy |
37,510
+69
| +0.2% | +$872 | ﹤0.01% | 4746 |
|
|
2024
Q3 | $602K | Buy |
37,441
+26,109
| +230% | +$420K | ﹤0.01% | 4568 |
|
|
2024
Q2 | $277K | Sell |
11,332
-2,325
| -17% | -$56.7K | ﹤0.01% | 4921 |
|
|
2024
Q1 | $981K | Buy |
13,657
+1,981
| +17% | +$142K | ﹤0.01% | 4176 |
|
|
2023
Q4 | $2.32M | Buy |
11,676
+87
| +0.8% | +$17.3K | ﹤0.01% | 3515 |
|
|
2023
Q3 | $1.54M | Buy |
11,589
+2,401
| +26% | +$319K | ﹤0.01% | 3740 |
|
|
2023
Q2 | $1.37M | Sell |
9,188
-8,217
| -47% | -$1.23M | ﹤0.01% | 3801 |
|
|
2023
Q1 | $2.55M | Sell |
17,405
-493
| -3% | -$72.4K | ﹤0.01% | 3523 |
|
|
2022
Q4 | $2.84M | Buy |
17,898
+11,731
| +190% | +$1.86M | ﹤0.01% | 3391 |
|
|
2022
Q3 | $1.19M | Buy |
6,167
+5,044
| +449% | +$971K | ﹤0.01% | 4067 |
|
|
2022
Q2 | $164K | Sell |
1,123
-3,392
| -75% | -$495K | ﹤0.01% | 5464 |
|
|
2022
Q1 | $794K | Sell |
4,515
-5,764
| -56% | -$1.01M | ﹤0.01% | 4775 |
|
|
2021
Q4 | $3.02M | Buy |
10,279
+9,138
| +801% | +$2.68M | ﹤0.01% | 3563 |
|
|
2021
Q3 | $283K | Buy |
1,141
+154
| +16% | +$38.2K | ﹤0.01% | 5226 |
|
|
2021
Q2 | $250K | Buy |
987
+17
| +2% | +$4.31K | ﹤0.01% | 5186 |
|
|
2021
Q1 | $172K | Buy |
970
+411
| +74% | +$72.9K | ﹤0.01% | 5471 |
|
|
2020
Q4 | $88K | Buy |
559
+94
| +20% | +$14.8K | ﹤0.01% | 5311 |
|
|
2020
Q3 | $120K | Sell |
465
-2,394
| -84% | -$618K | ﹤0.01% | 4970 |
|
|
2020
Q2 | $663K | Buy |
2,859
+2,787
| +3,871% | +$646K | ﹤0.01% | 3932 |
|
|
2020
Q1 | $12K | Buy |
72
+42
| +140% | +$7K | ﹤0.01% | 5694 |
|
|
2019
Q4 | $7K | Buy |
+30
| New | +$7K | ﹤0.01% | 5864 |
|